Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo

被引:23
作者
Van Themsche, C [1 ]
Potworowski, ÉF [1 ]
St-Pierre, Y [1 ]
机构
[1] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada
关键词
matrix metalloproteinases; stromelysin-1; lymphoma; gene regulation; invasion; tumor progression;
D O I
10.1016/j.bbrc.2004.01.144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinase (MMP)-3 (stromelysin-1) degrades various components of the extracellular matrix as well as several non-matrix components; it has notably been shown to activate other MMPs relevant to cancer and metastasis, including MMP-9. MMP-3 gene expression in the tumor microenvironment could therefore contribute to cancer progression. Transcriptional regulation of MMP genes was often described to occur upon intercellular interactions, leading to overexpression of these genes by cancer and/or stromal cells. In the present Work, we report that expression of MMP-3 in T lymphoma cells is transiently induced during specific intercellular contact with endothelial cells (EC). Moreover, mice injected with lymphoma cells expressing MMP-3 constitutively developed thymic lymphoma more rapidly than those injected with control lymphoma cells. We also found that overexpression. of MMP-3 in lymphoma transfectants significantly improved their ability to migrate through the matrix when compared to cells transfected with the control vector. These results provide the first in vivo evidence that local expression of MMP-3 promotes lymphoma progression and indicate that MMP-3 expression is tightly regulated upon lymphoma cell/stromal cell interaction. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:884 / 891
页数:8
相关论文
共 39 条
  • [1] Aoudjit F, 1998, J IMMUNOL, V160, P2967
  • [2] Arlt M, 2002, CANCER RES, V62, P5543
  • [3] Metalloproteinase inhibitors: biological actions and therapeutic opportunities
    Baker, AH
    Edwards, DR
    Murphy, G
    [J]. JOURNAL OF CELL SCIENCE, 2002, 115 (19) : 3719 - 3727
  • [4] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [5] DIRECT EVIDENCE LINKING EXPRESSION OF MATRIX METALLOPROTEINASE-9 (92-KDA GELATINASE/COLLAGENASE) TO THE METASTATIC PHENOTYPE IN TRANSFORMED RAT EMBRYO CELLS
    BERNHARD, EJ
    GRUBER, SB
    MUSCHEL, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4293 - 4297
  • [6] Changing views of the role of matrix metalloproteinases in metastasis
    Chambers, AF
    Matrisian, LM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) : 1260 - 1270
  • [7] Cornelius LA, 1998, J IMMUNOL, V161, P6845
  • [8] Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma
    De Angelis, T
    Noè, A
    Chatterjee, M
    Mulholland, J
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (05) : 759 - 766
  • [9] MMPs are IGFBP-degrading proteinases: Implications for cell proliferation and tissue growth
    Fowlkes, JL
    Serra, DM
    Nagase, H
    Thrailkill, KM
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 696 - 699
  • [10] Activation of ProMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model - Regulation by tissue inhibitors of metalloproteinases
    Hahn-Dantona, E
    Ramos-DeSimone, N
    Sipley, J
    Nagase, H
    French, DL
    Quigley, JP
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 : 372 - 387